| REGN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the REGN shares outstanding history going back to 2/12/2010:
Also see: REGN Market Cap History REGN YTD Return |
REGN Shares Outstanding History — Regeneron Pharmaceuticals Share Count Over Time
As of 4/14/2026 Regeneron Pharmaceuticals has 103.02 million REGN shares outstanding. Investors often track the REGN shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows REGN share count trends over time, with 65 historical shares outstanding datapoints presented, dating back to 2/12/2010.
| REGN Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REGN Historical Shares Outstanding: +1.62% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| REGN Stock Price Chart |
| About Regeneron Pharmaceuticals, Inc. |
| Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. Co. invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. We show 65 historical shares outstanding datapoints in our coverage of REGN's shares outstanding history. Understanding the changing numbers of REGN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like REGN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching REGN by allowing them to research REGN shares outstanding history as well as any other stock in our coverage universe. |
| REGN Current Stock Quote |
Quotes delayed 20 minutes  Free REGN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| REGN Share Performance |
| Shares Outstanding Peers |
| Regeneron Pharmaceuticals (REGN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RENB Shares Outstanding History REPH Shares Outstanding History REPL Shares Outstanding History REPR Shares Outstanding History RETA Shares Outstanding History REXN Shares Outstanding History RGEN Shares Outstanding History RGLS Shares Outstanding History RGNX Shares Outstanding History RIGL Shares Outstanding History More Healthcare companies » |
REGN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
